Skip to main content
Clinical Trials/NCT05876689
NCT05876689CompletedNot Applicable

Swept Source OCT Imaging With the DREAM VG-OCT

Robert T. Chang, MD1 site in 1 country154 target enrollmentStarted: October 9, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
154
Locations
1
Primary Endpoint
Assessing difference in intraocular structures

Study Overview

Brief Summary

The Intalight Dream OCT is the first combo anterior plus posterior device to perform both OCT and OCT-A at depth of 16mm. This is especially useful in patient who are very nearsighted as it allows us to image all in one frame. The intention of this study is to see how the images differ on the same patients when compared to the Cirrus OCT and to test for the repeatability of the images on a single day.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age greater than or equal to 18
  • Myopes with a current or previously documented spherical equivalent refraction < -4D
  • At least half of the subjects should have had at least one Cirrus OCT RNFL and macula performed as well as a Humphrey visual field performed in those with OCT abnormalities

Exclusion Criteria

  • Unable to comply with study imaging
  • unclear ocular media
  • Participant has, in the opinion of the investigator, any physical or mental condition that would affect the participation in the study or may interfere with the study procedures, evaluations and outcome assessments.

Outcomes

Primary Outcomes

Assessing difference in intraocular structures

Time Frame: Baseline

Assessing the performance of the DREAM VG OCT scan patterns in high myopes including glaucomatous eyes to see if there are differences in the lamina cribrosa structure when compared to patients previous Cirrus OCTs.

Assessing difference in intraocular vascular structures

Time Frame: Baseline

Assessing differences in vascular density in areas with presumed myopic-related field defects vs. low tension glaucoma perimetric disease

Secondary Outcomes

  • Assessing repeatability of scans(Baseline)

Investigators

Sponsor
Robert T. Chang, MD
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Robert T. Chang, MD

Associate Professor of Ophthalmology

Stanford University

Study Sites (1)

Loading locations...

Similar Trials